The short answer
First confirm it: four flat weeks at a steady dose, not two. Then work the levers you control for four weeks: protein at every meal, two strength sessions, more daily steps, and no liquid calories or grazing. If the scale still holds, the next levers belong to your prescriber: a dose step if one is left, a higher maintenance dose where the label allows it, or a different medication. Stopping or doubling up on your own backfires.
At GLP-1 SOS the plateau message usually arrives around month four or five, often with a plan that will not work: eat almost nothing, skip a shot, or double the next one. We have covered why a plateau is normal on a GLP-1 and what to check if your GLP-1 stopped working. This is the action plan.
At a glance
Break it in three stages
1
Confirm it
Four flat weeks at a steady dose, weighed once a week. Two flat weeks on a slowed gut is often water and stool.
2
Work your levers
Four weeks of protein first, strength twice a week, more steps, and no liquid calories or grazing.
3
Bring it to your prescriber
A dose step, a higher maintenance dose where the label allows, or a different medication. Their call, with your log.
Why the scale stops, and what can move it
A plateau is the point where what you eat and what you burn meet again. A smaller body burns less, appetite pushes back, and small meals quietly grow. The medication is usually still working; the gap it created has closed. Breaking a plateau means reopening that gap a little without starving your muscle.
Lifestyle is how these medications were tested, not a side note. The Wegovy and Zepbound labels both say to use the drug with a reduced-calorie diet and increased physical activity. In the STEP 3 trial, adults on semaglutide 2.4 mg with 30 counseling visits and an 8-week low-calorie diet lost 16.0% of their weight at 68 weeks. The Physical Activity Guidelines for Americans ask for at least 150 minutes of moderate activity a week plus strength work on two or more days.
Lab note
Reopen the gap a little. Never close it by starving the muscle that keeps your burn up.
What backfires is just as clear. Eating very little leaves you short on nutrients: the 2025 joint advisory on GLP-1 nutrition flags intakes under about 1,200 calories a day for women and 1,800 for men. Stopping the medication to reset it does not work either. In the STEP 4 trial, people who switched to placebo after 20 weeks regained 6.9% of their weight over the next 48 weeks, while those who stayed on semaglutide lost another 7.9%. And never double a dose: higher doses are a prescriber decision, made in steps.
When the levers you control are done, the medication levers come next. The Wegovy label, revised June 2026, allows a maximum of 7.2 mg once weekly for adults who have tolerated 2.4 mg for at least four weeks and need more weight reduction. Zepbound goes up to 15 mg. Some people switch medications; in a head-to-head trial of adults starting fresh, tirzepatide averaged 20.2% weight loss at 72 weeks and semaglutide 13.7%. That trial did not test switching mid-plateau, so it is a conversation, not a promise.
From the labels and trials
The numbers behind a plateau
18.8% vs 15.5%
average weight loss at 72 weeks on Wegovy 7.2 mg vs 2.4 mg, per the Wegovy label
+6.9%
weight regained in 48 weeks after switching from semaglutide to placebo, in the STEP 4 trial
20.2% vs 13.7%
average loss at 72 weeks on tirzepatide vs semaglutide in adults starting fresh, SURMOUNT-5
Sources: Wegovy Prescribing Information, June 2026; JAMA, 2021 (STEP 4); New England Journal of Medicine, 2025 (SURMOUNT-5).
What to do
- Weigh once a week for four weeks. Same day of the week, same scale, right after the bathroom. Add a waist measurement at the navel. If the waist moves while the scale holds, you are not stuck.
- Rebuild every plate around protein. Protein first, then vegetables, then the rest, stopping at satisfied. Our guide to protein sources and shakes when you can’t eat much lists the easiest options.
- Add strength twice a week. Twenty minutes of squats to a chair, wall push-ups, bands or light weights. Muscle is the part of your resting burn you can protect, and the guidelines ask for it on two or more days.
- Add steps where the day already has room. A ten-minute walk after each meal adds up to 210 minutes a week, past the guideline minimum of 150, and a gentle walk after eating is easy on a slowed stomach.
- Cut the calories that skip fullness. For three days, write down every drink and every bite between meals: coffee drinks, juice, smoothies, wine, shakes on top of meals. Liquids and grazing slip past the fullness signal the medication relies on.
- Keep things moving. Days without a bowel movement can hide a loss on the scale. Water through the day and a steady evening routine help. GLP-1 SOS Daily Gut Relief, 2 capsules with dinner, gives 250 mg of magnesium with ginger and peppermint to support regular bowel movements while you change how you eat.*
- Bring a one-page log to your prescriber. Your dose and the date of each step, four weekly weights and waists, and what you changed. Ask whether a step is left, whether a higher maintenance dose fits, or whether another option makes sense. Never change the dose yourself.
*GLP-1 SOS Daily Gut Relief supports regular bowel movements and digestive comfort. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Two kinds of moves
Plateau breakers, and plateau traps
Tends to help
- Protein first at every meal
- Two strength sessions a week
- More daily steps, walks after meals
- No liquid calories or grazing
- A four-week log for your prescriber
Tends to backfire
- Eating almost nothing
- Skipping shots to reset
- Doubling or changing a dose yourself
- Weighing every day and reacting
- Cutting protein to save calories
The fastest way off a plateau is usually the least dramatic one.
When to call your doctor
Call your prescriber the same day if:
- You think you injected more than your prescribed dose
- You have severe or persistent belly pain, with or without vomiting
- You are vomiting and cannot keep liquids down
- You feel shaky, sweaty or confused and also take insulin or a sulfonylurea
- You have pain in the upper right belly, fever, or yellow skin or eyes
- Your mood has dropped, or you notice thoughts of harming yourself (call or text 988 any time)
A plateau is a conversation for an ordinary visit. New symptoms are a same-day call.
From the people behind the Lab
You do not have to figure this out alone.
GLP-1 SOS is the daily companion made for life on a GLP-1. Plain answers like this one, a support team that replies to real questions from real people, and daily formulas like GLP-1 SOS Daily Gut Relief, designed around the side effects that come with the medication. The GLP-1 Lab is our free education arm: no login, no paywall, no hype. Side effects are part of the road. Suffering through them is not.
Questions people also ask
How long does a plateau on Ozempic or Wegovy last?
It depends on the cause. Two flat weeks are often water and stool, not a true plateau. A real plateau after months of loss lasts until something changes: what you eat, how much you move, or the dose. In the long trials weight curves flattened in the later months, so a late plateau may also be near the weight your body holds on that dose.
Should I increase my dose to break a plateau on Mounjaro or Zepbound?
Only your prescriber can decide that. The Zepbound label steps up in 2.5 mg increments, at least four weeks apart, to a maximum of 15 mg, and 2.5 mg is a starting dose only; Mounjaro is the same medicine. If you are below the maximum and tolerating your dose, a step may be an option. At 15 mg, the levers are lifestyle or a different medication. Never change the dose on your own.
Will skipping a week of my GLP-1 restart weight loss?
No. There is no evidence that a break resets the medication, and stopping tends to bring the weight back: in the STEP 4 trial, people switched from semaglutide to placebo regained 6.9% of their weight over 48 weeks. A skipped shot can also make the next one feel like a new dose step, with more nausea. Talk to your prescriber before any break.
Does intermittent fasting help break a GLP-1 plateau?
It helps some people eat less, but long gaps on an already small appetite are risky. They make protein targets harder, and the 2025 joint advisory notes GLP-1 nausea often comes after long periods without eating. If you try a shorter eating window, keep protein at every meal and do not drop below about 1,200 calories a day without medical supervision.
Is the Wegovy 7.2 mg dose for people who stopped losing weight?
It is for adults who have tolerated 2.4 mg for at least four weeks and need more weight reduction, per the June 2026 Wegovy label. In the label’s 72-week study, 7.2 mg averaged 18.8% weight loss and 2.4 mg averaged 15.5%. Stomach side effects can return with any increase. Whether it fits you, and whether insurance covers it, is a question for your prescriber.
Sources (7)
- Wegovy (semaglutide) injection and tablets, Prescribing Information. Novo Nordisk / FDA, revised June 2026.
- Zepbound (tirzepatide) injection, Prescribing Information. Eli Lilly, revised August 2026.
- Wadden TA, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA, 2021.
- Rubino D, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 2021.
- Aronne LJ, et al. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5). New England Journal of Medicine, 2025.
- Mozaffarian D, et al. Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory. American Journal of Clinical Nutrition, 2025.
- Physical Activity Guidelines for Americans, 2nd edition. U.S. Department of Health and Human Services, 2018.
Reviewed by the GLP-1 SOS editorial team · Education, not medical advice · Talk to your prescriber about your dose and your symptoms.
